최소 단어 이상 선택하여야 합니다.
최대 10 단어까지만 선택 가능합니다.
다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기Scientific reports, v.6, 2016년, pp.19622 -
Chang, Hen-Hong
(Research Center for Chinese Medicine and Acupuncture, and School of Chinese Medicine, China Medical University , Taichung, Taiwan)
,
Luo, Shue-Fen
(Division of Rheumatology, Allergy and Immunology, Chang Gung Memorial Hospital Linkou branch , Taoyuan, Taiwan)
,
Hsue, Yin-Tzu
(Division of Rheumatology, Allergy and Immunology, Department of Internal Medicine, Changhua Christian Hospital , Changhua, Taiwan)
,
Chang, Ching-Mao
(Center for Traditional Medicine, Taipei Veterans General Hospital , Taipei, Taiwan)
,
Lee, Tzung-Yan
(School of Traditional Chinese Medicine, College of Medicine, Chang Gung University , Taoyuan, Taiwan)
,
Huang, Yu-Chuen
(Department of Medical Research, China Medial University Hospital , Taichung, Taiwan)
,
Hsu, Ming-Ling
(Department of Medical Research, MacKay Memorial Hospital , Taipei, Taiwan)
,
Chen, Yu-Jen
(Department of Radiation Oncology, MacKay Memorial Hospital , Taipei, Taiwan
LC is an herbal remedy effectively reduced therapeutic dosage of glucocorticoid for systemic lupus erythematosus (SLE) patients in clinical trial (ISRCTN81818883). This translational research examined the impact of LC on biomarkers of endothelial injury in the enrolled subjects. Fifty seven patients...
Manzi S. . Age-specific incidence rates of myocardial infarction and angina in women with systemic lupus erythematosus: comparison with the Framingham Study . Am J Epidemiol 145 , 408 – 415 ( 1997 ). 9048514
Bauer J. W. . Elevated serum levels of interferon-regulated chemokines are biomarkers for active human systemic lupus erythematosus . PLoS Med 3 , e491 ( 2006 ). 17177599
Bauer J. W. . Interferon-regulated chemokines as biomarkers of systemic lupus erythematosus disease activity: a validation study . Arthritis Rheum 60 , 3098 – 3107 ( 2009 ). 19790071
Sacre K. . Increased arterial stiffness in systemic lupus erythematosus (SLE) patients at low risk for cardiovascular disease: a cross-sectional controlled study . PLoS One 9 , e94511 ( 2014 ). 24722263
Goon P. K. , Boos C. J. & Lip G. Y. Circulating endothelial cells: markers of vascular dysfunction . Clin Lab 51 , 531 – 538 ( 2005 ). 16285476
Lin Y. , Weisdorf D. J. , Solovey A. & Hebbel R. P. Origins of circulating endothelial cells and endothelial outgrowth from blood . J Clin Invest 105 , 71 – 77 ( 2000 ). 10619863
Zampetaki A. , Kirton J. P. & Xu Q. Vascular repair by endothelial progenitor cells . Cardiovasc Res 78 , 413 – 421 ( 2008 ). 18349136
Werner N. . Circulating endothelial progenitor cells and cardiovascular outcomes . N Engl J Med 353 , 999 – 1007 ( 2005 ). 16148285
Del Papa N. . Circulating endothelial cells as a marker of ongoing vascular disease in systemic sclerosis . Arthritis Rheum 50 , 1296 – 1304 ( 2004 ). 15077314
Rajagopalan S. . Endothelial cell apoptosis in systemic lupus erythematosus: a common pathway for abnormal vascular function and thrombosis propensity . Blood 103 , 3677 – 3683 ( 2004 ). 14726373
Tepper O. M. . Adult vasculogenesis occurs through in situ recruitment, proliferation, and tubulization of circulating bone marrow-derived cells . Blood 105 , 1068 – 1077 ( 2005 ). 15388583
Yang L. . Interleukin-1 beta increases activity of human endothelial progenitor cells: involvement of PI3K-Akt signaling pathway . Inflammation 35 , 1242 – 1250 ( 2012 ). 22371121
Fan Y. . Interleukin-6 stimulates circulating blood-derived endothelial progenitor cell angiogenesis in vitro . J Cereb Blood Flow Metab 28 , 90 – 98 ( 2008 ). 17519976
Rodriguez-Carrio J. . Circulating endothelial cells and their progenitors in systemic lupus erythematosus and early rheumatoid arthritis patients . Rheumatology (Oxford) 51 , 1775 – 1784 ( 2012 ). 22753774
Sales V. L. . Transforming growth factor-beta1 modulates extracellular matrix production, proliferation, and apoptosis of endothelial progenitor cells in tissue-engineering scaffolds . Circulation 114 , I193 – 199 ( 2006 ). 16820571
Thacker S. G. . The detrimental effects of IFN-alpha on vasculogenesis in lupus are mediated by repression of IL-1 pathways: potential role in atherogenesis and renal vascular rarefaction . J Immunol 185 , 4457 – 4469 ( 2010 ). 20805419
Denny M. F. . Interferon-alpha promotes abnormal vasculogenesis in lupus: a potential pathway for premature atherosclerosis . Blood 110 , 2907 – 2915 ( 2007 ). 17638846
Duda D. G. , Cohen K. S. , Scadden D. T. & Jain R. K. A protocol for phenotypic detection and enumeration of circulating endothelial cells and circulating progenitor cells in human blood . Nat Protoc 2 , 805 – 810 ( 2007 ). 17446880
Lin C. C. . Profiles of circulating endothelial cells and serum cytokines during adjuvant chemoradiation in rectal cancer patients . Clin Transl Oncol 15 , 855 – 860 ( 2013 ). 23401019
Ostensen M. Treatment with immunosuppressive and disease modifying drugs during pregnancy and lactation . Am J Reprod Immunol 28 , 148 – 152 ( 1992 ). 1285866
Ostensen M. & Forger F. Management of RA medications in pregnant patients . Nat Rev Rheumatol 5 , 382 – 390 ( 2009 ). 19506586
Deng X. L. , Li X. X. , Liu X. Y. , Sun L. & Liu R. Comparative study on circulating endothelial progenitor cells in systemic lupus erythematosus patients at active stage . Rheumatol Int 30 , 1429 – 1436 ( 2010 ). 19847436
Dome B. . Circulating bone marrow-derived endothelial progenitor cells: characterization, mobilization, and therapeutic considerations in malignant disease . Cytometry A 73 , 186 – 193 ( 2008 ). 18000872
Kahlenberg J. M. . Inflammasome activation of IL-18 results in endothelial progenitor cell dysfunction in systemic lupus erythematosus . J Immunol 187 , 6143 – 6156 ( 2011 ). 22058412
Mak A. & Kow N. Y. Imbalance between endothelial damage and repair: a gateway to cardiovascular disease in systemic lupus erythematosus . Biomed Res Int 2014 , 178721 ( 2014 ). 24790989
*원문 PDF 파일 및 링크정보가 존재하지 않을 경우 KISTI DDS 시스템에서 제공하는 원문복사서비스를 사용할 수 있습니다.
오픈액세스 학술지에 출판된 논문
※ AI-Helper는 부적절한 답변을 할 수 있습니다.